Riskpilot← Back to searchSign inGet full accessLäjeskliniken AB
ABActiveOrg 5563268324Nätvägen 1General medical practice activities · NACE 8621Est. 198824 employees
Revenue 2025
SEK 31,7M
-1% vs 2024
EBITDA margin
8.0%
-22% vs 2024
Equity ratio
13.0%
Financial strength
Net profit 2025
SEK 376K
-85% vs 2024
| Revenue | SEK 31,7M | -1% |
| EBITDA | SEK 2,5M | -22% |
| Net profit | SEK 376K | -85% |
| Total assets | SEK 7,1M | -17% |
| Equity | SEK 928K | -70% |
| Employees | 24 | — |
Legal name
Läjeskliniken AB
Org number
5563268324
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
7 juni 1988
Share capital
SEK 100 000
Employees
24 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Bolaget skall bedriva hälsovård, sjukvård, rehablilitering och därmed förenlig verksamhet.
Address
Nätvägen 1
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 29 158 | 27 831 | 29 999 | 31 985 | 31 718 |
| Staff expenses | — | −13 856 | −15 358 | −15 735 | −17 616 |
| EBITDA | 5 237 | 1 270 | 2 052 | 3 253 | 2 547 |
| Depreciation & amort. | −93 | −30 | −48 | −82 | −126 |
| EBIT | 5 144 | 1 239 | 2 003 | 3 171 | 2 421 |
| Net financials | −1 | −3 | −5 | 2 | 71 |
| Profit before tax | 476 | 1 236 | 1 998 | 3 174 | 492 |
| Tax | −108 | −266 | −439 | −671 | −116 |
| Net profit | 368 | 970 | 1 559 | 2 503 | 376 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 7 205 | 7 507 | 7 224 | 8 649 | 7 147 |
| Equity | 1 521 | 2 490 | 2 049 | 3 052 | 928 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 4 650 | 3 982 | 4 140 | 4 563 | 5 185 |
| Total debt | 4 650 | 3 982 | 4 140 | 4 563 | 5 185 |
EBITDA margin
8.0%
This company
15.8%
Market median
-49% vs market
20212025
Equity ratio
13.0%
This company
38.2%
Market median
-66% vs market
20212025
Return on equity
40.5%
This company
18.4%
Market median
+120% vs market
20212025
Net profit margin
1.2%
This company
8.1%
Market median
-85% vs market
20212025
Asset turnover
4.44×
This company
1.12×
Market median
+296% vs market
20212025
Debt / equity
6.70×
This company
0.62×
Market median
-981% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-06-30
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
HM Chief Auditor | Chief Auditor | 2020 |
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Board of Directors | 2020 | |
| Board of Directors | 2026 | |
| Chairman | 2026 | |
| Board of Directors | 2020 | |
| Former (2) | ||
| Board of Directors | 2020 – 2026 | |
| Chairman | 2020 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Läjeshälsan AB
Läjeskliniken AB Board members of Läjeskliniken AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Hans Magnus Peter Melén | Chief Auditor | 0 companies |
| Anna Viktoria Friman | Board of Directors | 0 companies |
| Erica Cecilia Winbo | Chairman | 0 companies |
| Carl Iwar Kristofer Mollberg | Board of Directors | 0 companies |
| Maja Linda Charlotta Mollberg | Board of Directors | 0 companies |
| Bengt-Olof Anders Isaksson | Chairman | 0 companies |
| Julia Therese Caroline Mårtensson | Board of Directors | 0 companies |